Related Experiment Videos

Microbial transformations of pergolide to pergolide sulfoxide and pergolide sulfone

Insights

Microbial biotransformation of pergolide yielded pergolide sulfoxide and sulfone metabolites. A Helminthosporium species efficiently converted pergolide enzymatically, demonstrating its potential for biotransformation applications.

Area of Science:

  • Microbiology
  • Biochemistry
  • Pharmacology

Background:

  • Pergolide, an ergoline alkaloid, is a dopamine agonist used in treating Parkinson's disease and hyperprolactinemia.
  • Investigating microbial biotransformation offers a sustainable approach to drug modification and metabolite production.

Purpose of the Study:

  • To screen microorganisms for their capacity to biotransform pergolide.
  • To identify and characterize the metabolites produced.
  • To evaluate the efficiency of enzymatic conversion versus spontaneous oxidation.

Main Methods:

  • Culturing of 58 microorganisms with pergolide.
  • Isolation and identification of metabolites using melting point, spectral analysis (e.g., NMR, MS), and chromatography (HPLC).
  • Enzymatic conversion assays and comparison with spontaneous air-oxidation controls.

Main Results:

  • A majority of tested microorganisms produced pergolide sulfoxide.
  • A Helminthosporium species yielded significant amounts of pergolide sulfoxide, with approximately 40% enzymatic conversion.
  • Pergolide sulfone was identified as a secondary metabolite in several organisms, including Aspergillus alliaceus.

Conclusions:

  • Microbial biotransformation is an effective method for generating pergolide metabolites.
  • Helminthosporium species demonstrate high potential for the enzymatic production of pergolide sulfoxide.
  • The study identified key metabolites and elucidated the biotransformation pathways of pergolide by microorganisms.

Related Concept Videos